366
Views
44
CrossRef citations to date
0
Altmetric
Research Papers

Lower proportions of CD4+CD25high and CD4+FoxP3, but not CD4+CD25+CD127low FoxP3+T cell levels in children with autoimmune thyroid diseases

, , , , , , , & show all
Pages 222-230 | Received 02 Sep 2012, Accepted 18 Nov 2012, Published online: 22 Jan 2013

References

  • Brand O. J., Gough S. C.. Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions. Curr. Genomics. 2011; 12 8: 526–541.
  • Wing J. B., Sakaguchi S.. Multiple treg suppressive modules and their adaptability. Front Immunol.. 2012; 3:178.
  • Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T.. Regulatory T cells: How do they suppress immune responses?. Int. Immunol.. 2009; 21 10: 1105–1111.
  • Holm T., Nielsen J., Claesson V.. CD4CD25 regulatory T cells: Phenotype and physiology. APMIS. 2004; 112:629–641.
  • Ohkura N., Sakaguchi V.. Regulatory T cells: Roles of T cell receptor for their development and function. Semin. Immunopathol.. 2010; 32 2: 95–106.
  • Baecher-Allan C., Viglietta V., Hafler D. A.. Human CD4+CD25+ regulatory T cells. Semin. Immunol.. 2004; 16:89–98.
  • Khattri R., Cox T., Yasayko S. A., Ramsdell F.. An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat. Immunol.. 2003; 4 4: 337–342.
  • Szypowska A., Stelmaszczyk-Emmel A., Demkow U., Luczyński W.. Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five. Arch. Immunol. Ther. Exp. (Warsz).. 2012; 60 4: 307–313.
  • Chavele K. M., Ehrenstein M. R.. Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett.. 2011; 585 23: 3603–3610.
  • Fountoulakis S., Vartholomatos G., Kolaitis N., . HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid. 2008; 18 11: 1195–1200.
  • Pan D., Shin Y. H., Gopalakrishnan G., Hennessey J., De Groot L. J.. Regulatory T cells in Graves' disease. Clin. Endocrinol. (Oxf).. 2009; 71 4: 587–593.
  • Wang S. H., Baker J. R.. The role of apoptosis in thyroid autoimmunity. Thyroid. 2007; 17 10: 975–979.
  • Bossowski A., Czarnocka B., Bardadin K., . Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis. Autoimmunity. 2008; 41 2: 163–173.
  • Lan R., Ansarib A., Liana Z., . Regulatory T cells: Development, function and role in autoimmunity. Autoimmun. Rev.. 2005; 4:351–363.
  • Mason D., Powrie F.. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol.. 1998; 6:649–655.
  • Boehmer von H.. Mechanisms of suppression by suppressor T cells. Nature Immunology. 2005; 5:338–344.
  • So T., Lee S. W., Croft M.. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev.. 2008; 19:253–262.
  • Nakano A., Watanabe M., Iida T., . Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid. 2007; 17 1: 25–31.
  • Marazuela M., García-López M. A., Figueroa-Vega N., . Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab.. 2006; 91 9: 3639–3646.
  • Zhou L., Lopes J. E., Lopes M. M., . TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature. 2008; 453 7192: 236–240.
  • Korn T., Mitsdoerffer M., Croxford A. L., . IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2008; 105 47: 18460–18465.
  • Dardalhon V., Korn T., Kuchroo V. K., Anderson A. C.. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun.. 2008; 31 3: 252–256.
  • Weetman A. P.. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat. Rev. Endocrinol.. 2010; 6 6: 311–318.
  • Guclu F., Ozmen B., Kirmaz C., . Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine. Eur. Cytokine Netw.. 2009; 20 1: 27–32.
  • Weetman A. P., Tandon N., Morgan B. P.. Antithyroid drugs and release of inflammatory mediators by complement-atttacted thyroid cells. Lancet. 1992; 340:633–666.
  • Marek-Trzonkowska N., Mysliwiec M., Dobyszuk A., . Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in Type 1 diabetes in children. Diabetes Care. 2012; 35 9: 1817–1820.
  • Thompson J. A., Perry D., Brusko T. M.. Autologous regulatory T Cells for the treatment of Type 1 diabetes. Curr. Diab. Rep.. 2012; 12 5: 623–632.
  • Morris G. P., Brown N. K., Kong Y. C.. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J. Autoimmun.. 2009; 33 1: 68–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.